Self-Collection and Molecular Diagnosis for Detection of Human Papillomavirus: Why Incorporate It?
- 698 Downloads
Purpose of Review
Cervical cancer, the third cause of death by cancer among Brazil’s women, is associated with human papillomavirus (HPV) infection. In some countries of South America, North America, Europe, and Oceania, initial screening for HPV DNA and subsequent follow-up with HPV-positive patients using colposcopy and cytological testing are used as preventative measures.
For HPV DNA detection, it is necessary to obtain cervical cells by conventional clinical collection method or self-collection of the cells that flake off from the uterine cervix and vaginal canal. Self-collection has been shown to be a viable option for obtaining samples and is a less invasive method that is more accepted by women. Thus, it can potentially decrease the limitations of the conventional clinical collection methods.
The efficiency of the self-collection method aligned with the implementation of HPV molecular testing, if adopted by public and private health care systems, may extend the reach of current cervical cancer prevention efforts. In addition, considering all phases from triage to treatment, this method may reduce health care costs and the time spent by patients and health care teams to conduct examinations and collect samples.
KeywordsCervical cancer HPV Prevention Diagnosis, self-collection method Molecular testing
Compliance with Ethical Standards
Conflict of Interest
Larissa Zatorre Almeida-Lugo, Camila Mareti Bonin-Jacob, Vanessa Terezinha Gubert de Matos, and Inês Aparecida Tozetti declare they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.•• INSTITUTO NACIONAL DO CÂNCER. Instituto Nacional de Câncer José de Alencar Gomes da Silva. Estimativa 2016-2017: Incidência de Câncer no Brasil. Rio de Janeiro, 2016. This study presents the estimated number of cervical cancer in Brazil by region, highlighting the high incidence of this neoplasm among women. Google Scholar
- 3.Oliveira ML, Amorim MMR, Souza ASR, Albuquerque LCB, Cota AAR. Infecção por chlamydia em pacientes com e sem lesões intra-epiteliais epiteliais cervicais. Rev Assoc Med Bras. 2008;54(6):506–12.Google Scholar
- 4.Redgrove KA, Mclaughlin EA. The role of the immune response in chlamydia trachomatis infection of the male genital tract: a double-edged sword. Front Immunol 2014; 27 (5): .534. doi: https://doi.org/10.3389/fimmu.2014.00534.eCollection 2014.
- 7.• Costa RFA, Longatto-Filho MA, Pinheiro C, Zeferino IC, Fregnani JH. Historical analysis of the Brazilian cervical cancer screening program from 2006 to 2013: a time for reflection. PLoS One. 2015. https://doi.org/10.1371/journal.pone.0138945 This study demonstrates the coverage and failures of cytopathological examination in Brazil, especially in underdeveloped regions. CrossRefGoogle Scholar
- 9.Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Intern J Canc. 2013;133(1):2681–7.Google Scholar
- 10.Bhatla N, Moda N. The clinical utility of HPV DNA testing in cervical cancer screening strategies. Ind J Med. 2009;130:261–5.Google Scholar
- 11.Eperon I, Vassilakos P, Navarria I, Menoud PA, Gauthier A, Pache JC, et al. Randomized comparison of vaginal self-sampling by standard vs dry swabs for human papillomavirus testing. BMC Cancer. 2013;353.Google Scholar
- 14.Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? Gynecol Oncol. 2007;105(2).Google Scholar
- 15.Campos KLM, Machado AP, Almeida FGD, Bonin CM, Prata TTM, Almeida LZ, Padovani CTJ, Ferreira, AMT, Fernandes CEDS, Tozetti IA. Good agreements between self and clinician-collected specimens for the detection of human papillomavirus in Brazilian patients. Mem do Inst Osw Cruz (Impresso) 2014; 109.Google Scholar
- 18.• Lavigne AW, Triedman SA, Randall TC, Trimble EL, Viswanathan AN. Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery. Gynecol Oncol. 2017;1(22):16–20. https://doi.org/10.1016/j.gore.2017.08.004 This study demonstrates the difficulty of access to preventive care for cervical cancer and the lack of choice for the management of the disease in underdeveloped regions. CrossRefGoogle Scholar
- 19.Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL; Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 18: 357(16):1579–1588.Google Scholar